on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Disclosure on Life Science Reit PLC
The Vanguard Group, Inc. has issued a Form 8.3 disclosure concerning its interest in Life Science REIT plc. As of March 24, 2025, Vanguard reported owning 1.00% of Life Science REIT plc's 1p ordinary shares, totaling 3,515,666 shares. There are no cash-settled or stock-settled derivative positions reported, nor any rights to new securities for the company.
The disclosure also notes the sale of 1,477 shares at 0.46 GBP each. There are no indemnity or other dealing arrangements related to the securities. Furthermore, no agreements, arrangements, or understandings regarding voting rights or future acquisitions/disposals linked to any derivatives exist.
No Supplemental Form 8 indicates open stock-settled derivative positions, and there are no changes in Vanguard's interest strategy regarding influential securities.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news